We studied the reasons surgical principal investigators chose not to enter patients in a large, multicenter trial sponsored by a cooperative group. In 1976 the National Surgical Adjuvant Project for Breast and Bowel Cancers (NSABP) initiated a clinical trial to compare segmental mastectomy and postoperative radiation, or segmental mastectomy alone, with total mastectomy. Because the low rates of accrual were threatening to close the trial prematurely, we mailed a questionnaire to the 94 NSABP principal investigators, asking why they were not entering eligible patients in the trial. A response rate of 97 per cent was achieved. Physicians who did not enter all eligible patients offered the following explanations: (1) concern that the doctor-patient relationship would be affected by a randomized clinical trial (73 per cent), (2) difficulty with informed consent (38 per cent), (3) dislike of open discussions involving uncertainty (22 per cent), (4) perceived conflict between the roles of scientist and clinician (18 per cent), (5) practical difficulties in following procedures (9 per cent), and (6) feelings of personal responsibility if the treatments were found to be unequal (8 per cent). Further investigation into the behavioral aspects of the investigator-patient relationship is particularly pressing, since fear of change in this relationship was the most common reason given for not entering eligible patients in the trial.
This article has been cited by other articles:
Williams, K. P., Mullan, P. B., Todem, D.
(2008). Moving from theory to practice: implementing the Kin KeeperSM Cancer Prevention Model. Health Educ Res
0: cyn026v1-cyn026
[Abstract][Full Text]
Trippel, S. B., Bosse, M. J., Heck, D. A., Wright, J. G.
(2007). Symposium. How to Participate in Orthopaedic Randomized Clinical Trials. JBJS
89: 1856-1864
[Full Text]
Chabner, B.
(2007). Phase II Cancer Trials: Out of Control?. Clin. Cancer Res.
13: 2307-2308
[Full Text]
Van Spall, H. G. C., Toren, A., Kiss, A., Fowler, R. A.
(2007). Eligibility Criteria of Randomized Controlled Trials Published in High-Impact General Medical Journals: A Systematic Sampling Review. JAMA
297: 1233-1240
[Abstract][Full Text]
Embi, P. J., Jain, A., Clark, J., Bizjack, S., Hornung, R., Harris, C. M.
(2005). Effect of a Clinical Trial Alert System on Physician Participation in Trial Recruitment. Arch Intern Med
165: 2272-2277
[Abstract][Full Text]
Wei, S.J., Metz, J.M., Coyle, C., Hampshire, M., Jones, H.A., Markowitz, S., Rustgi, A.K.
(2004). Recruitment of Patients Into an Internet-Based Clinical Trials Database: The Experience of OncoLink and the National Colorectal Cancer Research Alliance. JCO
22: 4730-4736
[Abstract][Full Text]
Rao, D. S., Phillips, E. R., Divine, G. W., Talpos, G. B.
(2004). Randomized Controlled Clinical Trial of Surgery Versus No Surgery in Patients with Mild Asymptomatic Primary Hyperparathyroidism. J. Clin. Endocrinol. Metab.
89: 5415-5422
[Abstract][Full Text]
Joffe, S., Harrington, D. P, George, S. L, Emanuel, E. J, Budzinski, L. A, Weeks, J. C
(2004). Satisfaction of the uncertainty principle in cancer clinical trials: retrospective cohort analysis. BMJ
328: 1463-
[Abstract][Full Text]
Penson, R. T., Daniels, K. J., Lynch, T. J. Jr.
(2004). Too Old to Care?. The Oncologist
9: 343-352
[Abstract][Full Text]
Garcia, J., Elbourne, D., Snowdon, C.
(2004). Equipoise: a case study of the views of clinicians involved in two neonatal trials. Clin Trials
1: 170-178
[Abstract]
Adams-Campbell, L. L., Ahaghotu, C., Gaskins, M., Dawkins, F. W., Smoot, D., Polk, O. D., Gooding, R., DeWitty, R. L.
(2004). Enrollment of African Americans Onto Clinical Treatment Trials: Study Design Barriers. JCO
22: 730-734
[Abstract][Full Text]
Wilson, J. T., Kearns, G., Springer, M. A.
(2003). Role of the Research-Subject Locator (RSL) in the Performance of a Pediatric Drug Trial. J Clin Pharmacol
43: 1196-1202
[Abstract][Full Text]
Whitney, S. N.
(2003). A New Model of Medical Decisions: Exploring the Limits of Shared Decision Making. Med Decis Making
23: 275-280
[Abstract]
Cassileth, B. R.
(2003). Clinical Trials: Time for Action. JCO
21: 765-766
[Full Text]
Comis, R. L., Miller, J. D., Aldige, C. R., Krebs, L., Stoval, E.
(2003). Public Attitudes Toward Participation in Cancer Clinical Trials. JCO
21: 830-835
[Abstract][Full Text]
Halpern, S. D., Karlawish, J. H. T., Berlin, J. A.
(2002). The Continuing Unethical Conduct of Underpowered Clinical Trials. JAMA
288: 358-362
[Abstract][Full Text]
Jordhuy, M S, Fayers, P M, Ahlner-Elmqvist, M, Kaasa, S
(2002). Lack of concealment may lead to selection bias in cluster randomized trials of palliative care. Palliat Med
16: 43-49
[Abstract]
Joffe, S., Cook, E. F., Cleary, P. D., Clark, J. W., Weeks, J. C.
(2001). Quality of Informed Consent: a New Measure of Understanding Among Research Subjects. JNCI J Natl Cancer Inst
93: 139-147
[Abstract][Full Text]
Weijer, C.
(2000). The Ethical Analysis of Risk. J Law Med Ethics
28: 344-361
Weijer, C., Shapiro, S. H, Glass, K. C., Enkin, M. W
(2000). For and against: Clinical equipoise and not the uncertainty principle is the moral underpinning of the randomised controlled trial FOR AGAINST. BMJ
321: 756-758
[Full Text]
Spiro, S G, Gower, N H, Evans, M T, Facchini, F M, Rudd, R M
(2000). Recruitment of patients with lung cancer into a randomised clinical trial: experience at two centres. Thorax
55: 463-465
[Abstract][Full Text]
Siminoff, L. A., Zhang, A., Colabianchi, N., Sturm, C. M. S., Shen, Q.
(2000). Factors That Predict the Referral of Breast Cancer Patients Onto Clinical Trials by Their Surgeons and Medical Oncologists. JCO
18: 1203-1211
[Abstract][Full Text]
Daugherty, C. K.
(1999). Impact of Therapeutic Research on Informed Consent and the Ethics of Clinical Trials: A Medical Oncology Perspective. JCO
17: 1601-1601
[Abstract][Full Text]
Edwards, S. J L, Lilford, R J, Hewison, J
(1998). The ethics of randomised controlled trials from the perspectives of patients, the public, and healthcare professionals. BMJ
317: 1209-1212
[Full Text]
Harrison, J. E
(1996). Patients should not be discouraged from entering trials. BMJ
313: 1488d-1488
[Full Text]
Bailar, J. C.
(1995). Surgery for Early Breast Cancer -- Can Less Be More?. NEJM
333: 1496-1498
[Full Text]
Angell, M., Kassirer, J. P.
(1994). Setting the Record Straight in the Breast-Cancer Trials. NEJM
330: 1448-1450
[Full Text]
Salzman, E. W.
(1985). Is Surgery Worthwhile? Presidential Address. Arch Surg
120: 771-776
[Abstract]